Literature DB >> 19128528

Negative affect predicts subsequent cognitive change in multiple sclerosis.

Christopher Christodoulou1, Patricia Melville, William F Scherl, William S Macallister, Rebecca L Abensur, Regina M Troxell, Lauren B Krupp.   

Abstract

Baseline predictors of cognitive change were explored in a sample of persons with multiple sclerosis (MS). Potential predictors included demographic features, baseline clinical characteristics, and psychological state. Participants were 38 individuals diagnosed with either relapsing remitting or secondary progressive MS who did not meet criteria for a current major depressive episode. Subjects were tested at baseline and approximately 1 year in an ongoing longitudinal study of cognition in MS. Participants completed neuropsychological tests sensitive to impairment in MS. They also completed self-report measures of depression, anxiety, fatigue, apathy, and positive and negative affect. Baseline measures of negative affect (e.g., depressed mood, state anxiety, and negative affective state) consistently predicted cognitive change over the course of the study. Higher baseline levels of negative affect were associated with greater relative declines in cognitive performance. This longitudinal relation occurred in the absence of a cross-sectional relation between negative affect and overall cognition. High baseline negative affect particularly predicted a relative decline in episodic memory for newly learned verbal and visuospatial information. The negative affect measures were unique in their predictive value among all the baseline measures assessed. (JINS, 2009, 15, 53-61.).

Entities:  

Mesh:

Year:  2009        PMID: 19128528     DOI: 10.1017/S135561770809005X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  5 in total

1.  Screening Instruments for the Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis.

Authors:  Sonya Kim; Vance Zemon; Joseph F Rath; MaryAnn Picone; Elizabeth S Gromisch; Heather Glubo; Lucia Smith-Wexler; Frederick W Foley
Journal:  Int J MS Care       Date:  2017 Jan-Feb

2.  Relationship Between Anxiety and Cognition in Multiple Sclerosis: Implications for Treatment.

Authors:  Nicholas A Vissicchio; Caroline Altaras; Amanda Parker; Shonna Schneider; Jeffrey G Portnoy; Roseanne Archetti; Marnina Stimmel; Frederick W Foley
Journal:  Int J MS Care       Date:  2019 Jul-Aug

3.  Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.

Authors:  Lampros Samartzis; Efthymia Gavala; Yiannis Zoukos; Achilleas Aspiotis; Thomas Thomaides
Journal:  Rehabil Res Pract       Date:  2014-09-01

4.  Cross-Sectional and Longitudinal Relationships between Depressive Symptoms and Brain Atrophy in MS Patients.

Authors:  Heiner Stuke; Katrin Hanken; Jochen Hirsch; Jan Klein; Fabian Wittig; Andreas Kastrup; Helmut Hildebrandt
Journal:  Front Hum Neurosci       Date:  2016-12-16       Impact factor: 3.169

5.  Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders.

Authors:  Ruth Ann Marrie; Ronak Patel; Charles N Bernstein; James M Bolton; Lesley A Graff; James J Marriott; Carol A Hitchon; Chase R Figley; Jennifer Kornelsen; John D Fisk
Journal:  Mult Scler       Date:  2020-09-25       Impact factor: 6.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.